In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency of early-stage molecule discovery is always the key factor determining project success ...

The “Lab-on-a-Molecule” team at the Wyss Institute is using DNA nanoswitch technology to develop an in vitro, high-throughput, platform to identify compounds for drug discovery. The nanoswitch is a ...

Ian Quigley was employee #13 at AI drug company Recursion until 2021, when he quit and turned the basement of his Utah home into a lab to develop AI models for predicting which proteins small molecule ...

Michael Jewett Ph.D. ’05, bioengineering and chemical engineering professor, has long been interested in how the living world works — and helping it work better. His lab’s most recent project, ReForm, ...

After a year of fastidious planning, a microscopic sample of the ultra-rare radioactive element berkelium arrived at a Berkeley Lab. With just 48 hours to experiment before it would become unusable, a ...